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Aim: Stepping source in brachytherapy systems is used to treat a target lesion longer than
the effective treatment length of the source. Cancerous lesions in the cervix, esophagus and
rectum are examples of such a target lesion.
Background: In this study, the stepping source of a GZP6 afterloading intracavitary brachyther-
apy  unit was simulated using Monte Carlo (MC) simulation and the results were used for
the  validation of the GZP6 treatment planning system (TPS).
Materials and methods: The stepping source was simulated using MCNPX Monte Carlo code.
Dose distributions in the longitudinal plane were obtained by using a matrix shift method for
esophageal tumor lengths of 8 and 10 cm. A mesh tally has been employed for the absorbed
dose calculation in a cylindrical water phantom. A total of 5 × 108 photon histories were
scored and the MC statistical error obtained was at the range of 0.008–3.5%, an average of
0.2%.
Results: The acquired MC and TPS isodose curves were compared and it was shown that the
dose  distributions in the longitudinal plane were relatively coincidental. In the transverse
direction, a maximum dose difference of 7% and 5% was observed for tumor lengths of 8
and  10 cm, respectively.
Conclusion: Considering that the certiﬁed source activity is given with ±10% uncertainty,
the obtained difference is reasonable. It can be concluded that the accuracy of the dose
distributions produced by GZP6 TPS for the stepping source is acceptable for its clinical
applications.
©  2012 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
601.  BackgroundBrachytherapy is a method of treatment in which sealed
radioactive sources are used to deliver radiation to tumor at
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a short distance through interstitial, intracavitary or surface
applications.1 Although not as widespread as 192Ir sources,y, North Khorasan University of Medical Sciences, South Shariati
8 584 2247124; fax: +98 584 2247124.
Co is also available on afterloading equipment dedicated to
high dose rate (HDR) brachytherapy.2 In modern brachyther-
apy, treatment planning is performed to deﬁne a planning
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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Fig. 1 – A schematic diagram illustrating the steppingreports of practical oncology and 
arget volume (PTV) and to spare adjacent critical structures.
ptimization procedure in the determination of the treatment
arameters is usually to minimize the variations of the dose
alues on the surface of the PTV. This aim is achieved by
eﬁning a number of points on the PTV surface and determin-
ng dwell times (dwell weights) for the source dwell positions
ithin the applicators. For this purpose, stepping sources are
sed as an option and are loaded in the applicator.3 Sev-
ral Monte Carlo methods have been employed to assess the
bsorbed dose near brachytherapy stepping sources.4–7 Also
here are other Monte Carlo based studies in which dose dis-
ributions were calculated around non stepping brachytherapy
ources.8,9 Since the treatment planning process is very impor-
ant in assuring an optimum treatment in brachytherapy the
etermination of dose distribution becomes an important
ask. Therefore, it is necessary to know the extent of dosi-
etric errors including over- or under-dosage of the target
olume.7 The quality control of treatment planning has been
he subject of several studies, and was reviewed in the report
y task group (TG) number 59 of the American Association
f Physicists in Medicine (AAPM).10 There are different stud-
es which have already been performed on the GZP6 unit.
ahreyni et al. evaluated air kerma strength for the GZP6
ource no. 3 certiﬁed by GZP6 unit through in-air measure-
ents and Monte Carlo simulations of this source.11 Mesbahi
erformed a Monte Carlo study on calculation of radial dose
unction for the GZP6 sources nos. 1, 2 and 5.12 Naseri and Mes-
ahi in another study simulated the three mentioned GZP6
ources and veriﬁed dose distributions for the three sources
ased on comparisons of the dose distributions obtained from
onte Carlo method by those from GZP6 treatment planning
ystem.13 As another study, they measured air kerma strength
or the three mentioned GZP6 sources.14 In a previous work by
ahreyni et al. a matrix shift method was developed toward
imulation of stepping movement  of the GZP6 source no. 6.15
.  Aim
s far as we  are aware, at the current time there is no published
eport on the veriﬁcation of dose distributions using the GZP6
reatment planning system for the stepping source (source no.
). In this study, the dose distributions calculated by the GZP6
reatment planning system for the stepping source were eval-
ated using Monte Carlo simulation and the application of a
atrix shift method.
. Materials  and  methods
.1.  GZP6  stepping  source
ZP6 afterloading unit (manufactured by the Nuclear Power
nstitute of China) has six 60Co source braids including one
tepping and ﬁve non-stepping source braids. It is used for
ntracavitary treatments such as brachytherapy of cervix, rec-
um, esophagus and nasopharynx malignancies. The GZP6
tepping source consists of a 60Co active cylinder with diam-
ters of 2 mm and 1 mm.  The source has a very thin nickel
lating which is covered by a titanium capsule. The over-
ll length of the titanium capsule is 3.5 mm and its outersource of the GZP6 brachytherapy unit.
diameter is 1.5 mm.  There are a number of inactive steel
pellets in the source braid with a diameter of 1.5 mm.  The
active and non-active pellets are covered by a steel spring.
A schematic representation of the GZP6 stepping source is
illustrated in Fig. 1.
3.2.  Treatment  planning
GZP6 unit is composed of an afterloading system as well as
a treatment planning system. The name of the TPS is GZP6
treatment planning system. This planning system displays
dose distribution in the form of isodose curves for the GZP6
sources. The treatment planning system uses Sievert integral
for its dose calculations. In the Sievert integral method, a lin-
ear source is divided into several segments. Each segment is
small enough to be assumed as a point source. Using point
source approximation, the integration of the exposure rate
contributions from each segment to a given point is then cal-
culated. The following equation represents a classical Sievert
integral:
I(x, y) = Meq ·  Ra
Ly
et
′
∫ 2
1
e−t sec 
′
d′ (1)
In which, Meq is total source strength (mg Ra Eq); Ra is
exposure rate constant of 226Ra source, with 0.5 mm of plat-
inum ﬁlter. L is the active length of the source; ′ is effective
attenuation coefﬁcient of the source capsule; and t is thickness
of the source capsule.
When the source strength is speciﬁed in terms of air kerma
strength (SK), Eq. (1) will be changed to the following one16:
I(x, y) = SK
Ly(W/e)
et
′
∫ 2
1
e−t sec 
′
d′ (2)
Esophagus and cervical cancer treatments are being per-
formed in our center using the GZP6 stepping source. The
main difference between the dose distributions used in the
treatment of esophagus and cervical cancer is related to the
difference in the material used in their applicators. The appli-
cator used for treating esophageal cancer is made of plastic
while the one used for cervical cancer is of stainless steel. In
the present study, the dose distributions were only obtained
in the longitudinal plane for the treatment of esophageal can-
cer by GZP6 treatment planning system. The obtained dose
distributions from the GZP6 treatment planning system are
based on a dose value of 5 Gy prescribed to the point 0, 0, 1 cm
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Table 1 – Mass density and composition of the materials
used in the Monte Carlo simulations.
Material:
description
Mass density
(g/cm3)
Composition
(ele-
ment/weight
fraction)
Cobalt: source
core
8.85  Co/1
Nickel: source
plating
8.902  Ni/1
Titanium: source
capsule
4.54 Ti/1
Steel pellets:
spacers in the
source braid
7.9  Fe/0.71994, C/0.0005,
Si/0.0072, Mn/0.0137,
S/0.00011, P/0.00025,
Cr/0.17, Ni/0.0822,
Mo/0.0013, V/0.0006,
Ti/0.0042
Steel: spring
cover
6.999  Fe/0.7416, Ni/0.069,
S/0.0001, Cr/0.167,
C/0.0006, Mn/0.0062,
Cu/0.0026, Al/0.0062,
Mo/0.0015, Si/0.0052
Air 0.001205 C/0.000124, N/0.7555267,
O/0.231781, Ar/0.012827
The dose distributions related to the treatment length of 8 cmWater: phantom
material
1 H/0.111894, O/0.888106
relative to the central step. The related number of steps, the
time interval between the steps and the source activity were
recorded and applied to our Monte Carlo simulations.
3.3.  Monte  Carlo  simulations
To calculate dose distributions for the GZP6 stepping source,
the GZP6 stepping source was simulated using MCNPX (ver-
sion 2.4.0) Monte Carlo code.17 MCNPX is a general purpose
Monte Carlo code for transporting neutrons, photons, elec-
trons, and other particles in various geometries. It includes
a geometry modeling tool and various tallies related to energy
deposition, particle current, and particle ﬂux.18 This code uses
the MCPLIB02 cross section library for transport of photons.
A cylindrical water phantom with a length of 80 cm and a
diameter of 50 cm was also simulated. The source was located
at the center of the simulated water phantom. To describe
the photon spectrum of 60Co source, two photons with 1.17
and 1.33 MeV  energies and equal emission probabilities were
deﬁned in the source deﬁnition card. Mass density and com-
position of various components of the GZP6 source, air and
water phantom used in our Monte Carlo simulations are listed
in Table 1.
The simulations were performed in both photon and elec-
tron modes. The absorbed dose in the mesh pixels was
calculated for photons using a type 1 mesh tally with a “pedep”
option (photon energy deposition). The pedep option in a mesh
tally (type 1) scores the average energy deposited per unit
volume for the particle type P (photon) (MeV/cm3/source par-
ticle). This tally is different from other tallies in MCNP code. In
contrast to the 3rd type of mesh tally, energy deposition can
be obtained in this option for any particular particle. At the
points in which charged particle equilibrium exists, absorbed
dose for photons can be approximated by kerma. In MCNPiotherapy 1 8 ( 2 0 1 3 ) 112–116
code, F6 tally is used to score kerma. Therefore, at the points
with a charged particle equilibrium, photon dose values can
be obtained by scoring F6 tally the tally cells. However for cal-
culation of dose in mesh tally cells the F6 tally cannot be used
and instead, as mentioned in the MCNPX manual, the pedep
option in a type 1 mesh tally allows one to score the equivalent
of an F6:P heating tally for the particle type P (photon).17 The
energy cut off of 1 keV was used for photons and electrons and
no other variance reduction techniques were used. This mesh
tally type with pedep option has been used in a previous study
by Gifford et al. to calculate dose values around a brachyther-
apy tandem applicator.18 The dimensions of a rectangular
mesh were 280 pixels ×280 pixels ×1 pixel. The resolution of
the rectangular mesh was 0.05 cm.  The used rectangular mesh
corresponds to a 14 cm × 14 cm × 0.05 cm space. The conver-
sion program, “gridconv”, was used for the conversion of the
mesh tally output ﬁle to a text ﬁle. The pedep option in a mesh
tally scores the average energy deposited per unit volume
for a source particle (MeV/cm3/source particle). The outputs
were converted to dose in Gy by multiplying it by the cor-
responding conversion coefﬁcients. The coefﬁcients include
the source activity, a number of coefﬁcients for conversion of
units, radiation fractional yield of 60Co (number of photons
emitted per disintegration), etc. A total of 5 × 108 photon his-
tories were scored and the obtained MC statistical error of the
calculations was in the range of 0.008–3.5% with an average
of 0.2%. A service pack 2 of Microsoft Windows XP (profes-
sional) software, a Pentium III CPU, 2 GB RAM memory,  was
used for our MC  simulation. Except for energy cut off, we  did
not use any other variance reduction technique. The compu-
tation time needed to complete 5 × 108 photon histories was
about 20 days.
In this study, matrix shift method was applied to obtain
the isodose curves in the longitudinal plane for the treatment
of esophageal tumor length of 8 and 10 cm.  According to this
method for considering the stepping movement  of the source
in the longitudinal plane, it is assumed that the source is sta-
tionary and, instead, the data matrix is shifted. The number of
shifts is equal to the number of steps. Dose distribution data
matrix is obtained using a mesh tally which can be deﬁned
in MCNP Monte Carlo code. Following various shifts in the
dose data matrix, the ﬁnal dose data matrix is obtained by
summing up the matrices from various shifts. The summation
and plotting the isodose contours can be performed in MAT-
LAB software environment. More details on this method can
be found in the study by Bahreyni et al.15 In our applications,
the data matrix was shifted 31 and 38 steps to obtain the iso-
dose curves related to 8 and 10 cm tumor lengths, respectively.
Finally, all matrices were summed up and the isodoses for
dose contours of 1.25, 2.5, 3.75, 5, 6.25 and 7.5 Gy were plotted.
Matrix shifting was performed in MATLAB (version 7.2.0.232,
MathWorks, Inc., Natwick, MA, USA) environment.
4.  Resultsof esophageal tumor in the longitudinal plane for the GZP6
stepping source, obtained by Monte Carlo simulation and GZP6
treatment planning system are illustrated in Fig. 2. In this
reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) 112–116 115
Fig. 2 – Dose distributions for the GZP6 stepping source
obtained by MC  simulation and the GZP6 TPS for
esophageal cancer tumor length of 8 cm.  MC  contours are
shown by sharp clear curves and TPS contours by the blunt
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Fig. 3 – Dose distributions for the GZP6 stepping source
obtained by MC simulation and the GZP6 TPS for
esophageal cancer tumor length of 10 cm.  MC  contours are
shown by sharp clear curves and TPS contours by the bluntnclear curves.
gure, the dose contours corresponding to 1.25, 2.5, 3.75, 5,
.25 and 7.5 Gy dose values are plotted from peripheral to cen-
ral regions and the solid ﬁne points on the horizontal axis
llustrate the source positions.
The comparison of MC  and TPS dose distributions shows
hat the isodose curves are coincidental in the longitudinal
irection, however in the transverse direction (Y-axis direction
n the Y–Z plane as shown in Figs. 2 and 3), a maximum dose
ifference of 7% is observed between the dose distributions
btained by the two  mentioned methods.
The dose distributions related to the treatment length of
0 cm of esophageal tumor in the longitudinal plane for the
ZP6 stepping source, obtained by Monte Carlo simulation and
ZP6 treatment planning system are illustrated in Fig. 3. In
his ﬁgure, the dose contours corresponding to 1.25, 2.5, 3.75,
, 6.25 and 7.5 Gy dose values are plotted from peripheral to
entral regions and the solid ﬁne points on the horizontal axis
llustrate the source positions.
The comparison of MC  and TPS dose distributions shows
hat the isodose curves are coincidental in the longitudinal
irection. However in the transverse direction (Y-axis direc-
ion on the Y–Z plane as shown in Figs. 2 and 3), a maximum
ose difference of 5% is observed between the dose distribu-
ions obtained by the two mentioned methods.
.  Discussion  and  conclusions
n the present study, the GZP6 stepping source was simu-
ated and the results were used toward validation of dose
istributions certiﬁed by the GZP6 treatment planning sys-
em. Although the obtained results show that the maximum
ifference between MC  and TPS calculations is about 7%,unclear curves.
considering that the certiﬁed source activity (which was used
in our MC calculations) is given with ±10% uncertainty, the
difference is reasonable. Generally speaking, by keeping in
mind this level of uncertainty in source activity, the accuracy
of the dose distributions produced by GZP6 TPS for the step-
ping source is acceptable for its clinical application. However,
in both Monte Carlo and TPS methods the theoretical activity,
with ±10% uncertainty, is used as an input in dose distribu-
tion calculations. Performing a precise measurement of GZP6
stepping source’s activity can lead to a lower uncertainty in
the source activity. Then, inputting the measured activity in
Monte Carlo calculations may result in a lower level of differ-
ence between the MC and GZP6 TPS dose distributions.
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